Oaktree Acquisition Corp. III Life Sciences focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It intends to acquire companies in the biopharmaceutical, medical devices, diagnostics, and specialized healthcare services sectors in North America and Europe. The company was incorporated in 2024 and is based in Los Angeles, California.

Company Data

Name Oaktree Acquisition Corp. III Life Sciences - Class A Ordinary Share

Company Oaktree Acquisition Corp. III Life Sciences

Symbol OACC

Website https://www.oaktreeacquisitioncorp.com/oac-iii

Primary Exchange

NASDAQ

ISIN KYG6717R1048

Asset Class Share

Sector Financial Services

Industry Shell Companies

CEO Zaid Pardesi

Market Capitalization 256 Mio

Country United States of America

Currency USD

Employees 0,0 T

Address 333 South Grand Avenue, 90071 Los Angeles

IPO Date 2024-12-16

Ticker Symbols

Name	Symbol
NASDAQ	OACC

More Shares

Investors who hold Oaktree Acquisition Corp. III Life Sciences - Class A Ordinary Share also have the following shares in their portfolio:

American Funds 2045 Trgt Date Retire A Fund

XTR.S+P 500 SWAP 1CDL ETF

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog